1997
Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs
Grace A, Bunney B, Moore H, Todd C. Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs. Trends In Neurosciences 1997, 20: 31-37. PMID: 9004417, DOI: 10.1016/s0166-2236(96)10064-3.Peer-Reviewed Original ResearchConceptsDepolarization blockAntipsychotic drugsDopamine systemNigrostriatal dopamine systemWeeks of treatmentExtrapyramidal side effectsAntipsychotic drug efficacyDopamine receptor antagonistDrug treatment resultsMesolimbic dopamine neuronsTreatment of schizophreniaDopamine neuron firingReceptor blockadeDopamine neuronsTherapeutic impactSide effectsClinical actionsDrug AdministrationTherapeutic efficacyTreatment resultsDrug efficacyTherapeutic actionPotential mechanismsDrugsEfficacy
1992
Actions of Neurotensin: A Review of the Electrophysiological Studiesa
SHI W, BUNNEY B. Actions of Neurotensin: A Review of the Electrophysiological Studiesa. Annals Of The New York Academy Of Sciences 1992, 668: 129-145. PMID: 1463269, DOI: 10.1111/j.1749-6632.1992.tb27345.x.Peer-Reviewed Original ResearchMeSH KeywordsNeurotensinConceptsExcitatory effectsDA cellsModulatory effectsDA receptor blockadeDirect postsynaptic effectAction of neurotensinGlutamate-induced excitationMidbrain DA cellsMembrane conductancePostsynaptic effectsReceptor blockadeDepolarization inactivationNT receptorsCell activityFiring rateSame receptorNeuromedin NSudden cessationHigh concentrationsProtein kinase CBasal activityToxic effectsInhibitionNeurotensinReceptors
1991
Effects of neurotensin on midbrain dopamine neurons: Are they mediated by formation of a neurotensin—dopamine complex?
Shi W, Bunney B. Effects of neurotensin on midbrain dopamine neurons: Are they mediated by formation of a neurotensin—dopamine complex? Synapse 1991, 9: 157-164. PMID: 1776128, DOI: 10.1002/syn.890090302.Peer-Reviewed Original ResearchConceptsEffects of neurotensinNeurotensin receptorsDopamine neuronsDopamine cellsCell activitySingle-unit recording techniquesFiring rateMidbrain dopamine neuron activityAction of neurotensinBasal firing rateDopamine receptor blockadeDopamine-induced inhibitionDopamine neuron activityMidbrain dopamine neuronsReceptor blockadeDepolarization inactivationExcitatory effectsNative neurotensinBrain slicesNeuron activityNeurotensinNeurotensin analoguesSame receptorRecording techniquesReceptors
1989
The effect of acute and chronic treatment with SCH 23390 on the spontaneous activity of midbrain dopamine neurons
Esposito E, Bunney B. The effect of acute and chronic treatment with SCH 23390 on the spontaneous activity of midbrain dopamine neurons. European Journal Of Pharmacology 1989, 162: 109-113. PMID: 2656273, DOI: 10.1016/0014-2999(89)90609-2.Peer-Reviewed Original ResearchConceptsSubstantia nigra pars compactaVentral tegmental areaActive DA neuronsSCH 23390Chronic treatmentDA neuronsDopamine neuronsDepolarization blockSpontaneous activityDA receptor blockadeAcute subcutaneous injectionGroups of ratsMidbrain dopamine neuronsChronic haloperidolReceptor blockadeChronic administrationPars compactaTegmental areaAntipsychotic drugsSubcutaneous injectionChronic experimentsMarked reductionNeuronsTreatmentHaloperidol
1987
Electrophysiological studies on the specificity of the cholecystokinin antagonist proglumide
Chiodo L, Freeman A, Bunney B. Electrophysiological studies on the specificity of the cholecystokinin antagonist proglumide. Brain Research 1987, 410: 205-211. PMID: 3036308, DOI: 10.1016/0006-8993(87)90317-9.Peer-Reviewed Original ResearchConceptsExcitatory effectsInhibitory effectA9 DA neuronsCCK receptor blockadeSelective CCK antagonistsMidbrain dopamine cellsPrefrontal cortical neuronsInhibitory potencyDA neuronsReceptor blockadeChronic treatmentSensorimotor cortexCCK antagonistsC-terminal octapeptideDA cellsSubstance PAPO effectsCortical neuronsDopamine cellsIntravenous administrationSelective antagonistRat CNSProglumideElectrophysiological studiesCholecystokininChronic Neuroleptic Effects on Dopamine Neuron Activity: A Model for Predicting Therapeutic Efficacy and Side Effects?
Freeman A, Bunney B. Chronic Neuroleptic Effects on Dopamine Neuron Activity: A Model for Predicting Therapeutic Efficacy and Side Effects? Psychopharmacology Series 1987, 3: 225-235. PMID: 2881290, DOI: 10.1007/978-3-642-71288-3_26.Peer-Reviewed Original ResearchConceptsMost psychotic patientsDA receptor blockerTreatment of choiceDopamine neuron activityCentral catecholamine systemsReceptor blockadeReceptor blockersCatecholamine neuronsNeuroleptic effectsMajor symptomsAntipsychotic drugsCatecholamine systemsAntipsychotic propertiesForebrain regionsNeuronal activityCatecholamine receptorsSide effectsDopamine systemNeuron activityPsychotic patientsTherapeutic efficacyMode of actionFeedback pathwaysTreatmentNeuroleptics